SJM Holdings Valuation

Is 3MG undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 3MG when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 3MG (€0.31) is trading below our estimate of fair value (€0.9)

Significantly Below Fair Value: 3MG is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 3MG?

Key metric: As 3MG is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for 3MG. This is calculated by dividing 3MG's market cap by their current revenue.
What is 3MG's PS Ratio?
PS Ratio0.7x
SalesHK$26.06b
Market CapHK$18.82b

Price to Sales Ratio vs Peers

How does 3MG's PS Ratio compare to its peers?

The above table shows the PS ratio for 3MG vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average2.2x
TIMA ZEAL Network
6.3x14.3%€955.1m
0.2x3.8%€3.8b
EMH pferdewetten.de
1.3x27.1%€25.4m
DHER Delivery Hero
1x11.1%€11.1b
3MG SJM Holdings
0.7x8.4%€18.8b

Price-To-Sales vs Peers: 3MG is good value based on its Price-To-Sales Ratio (0.7x) compared to the peer average (2.2x).


Price to Sales Ratio vs Industry

How does 3MG's PS Ratio compare vs other companies in the DE Hospitality Industry?

2 CompaniesPrice / SalesEstimated GrowthMarket Cap
MS1 Marley Spoon Group
0.1x10.0%US$18.89m
9UX Hostmore
0.0006xn/aUS$138.43k
No more companies available in this PS range
3MG 0.7xIndustry Avg. 1.0xNo. of Companies3PS00.61.21.82.43+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: 3MG is good value based on its Price-To-Sales Ratio (0.7x) compared to the European Hospitality industry average (1x).


Price to Sales Ratio vs Fair Ratio

What is 3MG's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

3MG PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.7x
Fair PS Ratio1.9x

Price-To-Sales vs Fair Ratio: 3MG is good value based on its Price-To-Sales Ratio (0.7x) compared to the estimated Fair Price-To-Sales Ratio (1.9x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 3MG forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€0.31
€0.43
+35.7%
33.1%€0.88€0.28n/a17
Nov ’25€0.31
€0.42
+36.3%
33.0%€0.85€0.27n/a15
Oct ’25€0.35
€0.37
+4.9%
38.8%€0.82€0.25n/a15
Sep ’25€0.27
€0.38
+41.2%
36.3%€0.83€0.26n/a15
Aug ’25€0.29
€0.41
+42.3%
33.3%€0.84€0.26n/a16
Jul ’25€0.31
€0.43
+39.7%
30.5%€0.85€0.27n/a16
Jun ’25€0.34
€0.42
+23.6%
31.8%€0.85€0.27n/a16
May ’25€0.34
€0.40
+19.0%
34.6%€0.86€0.26n/a16
Apr ’25€0.27
€0.40
+47.6%
37.2%€0.85€0.25n/a16
Mar ’25€0.27
€0.41
+52.4%
38.7%€0.85€0.23n/a16
Feb ’25€0.26
€0.41
+58.4%
38.2%€0.84€0.22n/a16
Jan ’25€0.28
€0.44
+56.8%
32.5%€0.85€0.27n/a18
Dec ’24€0.26
€0.46
+78.0%
32.8%€0.83€0.28n/a17
Nov ’24€0.31
€0.52
+65.7%
27.9%€0.86€0.36€0.3115
Oct ’24€0.36
€0.51
+40.2%
28.3%€0.86€0.33€0.3516
Sep ’24€0.36
€0.51
+41.2%
26.1%€0.84€0.32€0.2717
Aug ’24€0.41
€0.51
+24.5%
26.1%€0.82€0.32€0.2917
Jul ’24€0.39
€0.55
+40.6%
23.7%€0.84€0.32€0.3115
Jun ’24€0.37
€0.55
+48.3%
23.5%€0.85€0.33€0.3416
May ’24€0.46
€0.55
+18.5%
22.9%€0.83€0.32€0.3415
Apr ’24€0.46
€0.56
+23.2%
22.9%€0.84€0.32€0.2715
Mar ’24€0.50
€0.58
+16.5%
24.8%€0.85€0.33€0.2717
Feb ’24€0.52
€0.57
+9.5%
24.7%€0.84€0.32€0.2617
Jan ’24€0.54
€0.52
-3.5%
29.4%€0.87€0.34€0.2817
Dec ’23€0.47
€0.49
+4.4%
31.7%€0.87€0.34€0.2617
Nov ’23€0.33
€0.51
+55.3%
33.9%€0.92€0.32€0.3117

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.


Discover undervalued companies